Skip to main content
Clinical Trials/NL-OMON55574
NL-OMON55574CompletedNot Applicable

Protein-specific turnover in the human brain; Measuring protein-specific synthesis rates of the human brain using the D2O dosing method - D2O in Brain

niversiteit Maastricht0 sites12 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
12

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • * Written informed consent
  • * Male and female patients scheduled for temporal lobectomy
  • * Age 18 - 65 years
  • * Compos mentis

Exclusion Criteria

  • * Comorbidities and neuromuscular disorders of the lower limbs severely
  • interacting with mobility, with limited or no opportunity for improvement (e.g.
  • cerebral palsy)
  • * Peripheral artery disease Fontaine III or IV
  • * Chronic Obstructive Pulmonary Disease (COPD) GOLD III or IV
  • * Use of systemic steroids in the past four weeks, other than indicated for the
  • specific type of surgery
  • * Use of anti-inflammatory biologicals (e.g. TNF-alfa blockers) in the past
  • * Surgical intervention in the past four weeks
  • * Total parenteral nutrition at day of surgery
  • * Pregnancy
  • * Neoadjuvant chemotherapy or radiotherapy

Investigators

Similar Trials